iSpecimen to Participate in the H.C. Wainwright 23rd Annual Global Investment Conference on September 13-15, 2021

LEXINGTON, Mass.: LEXINGTON, Mass., Sept. 1, 2021 /PRNewswire/ — iSpecimen Inc. (Nasdaq: ISPC) ("iSpecimen" or the "Company"), an online marketplace for human biospecimens, today announced that Christopher Ianelli, MD, PhD, CEO and President of iSpecimen, will participate in the H.C. Wainwright 23rd Annual Global Investment Conference to be held virtually on September 13-15, 2021. Dr. Ianelli’s corporate presentation will be available on-demand starting Monday, September 13, 2021 at 7:00 a.m. ET.
Click here to view original post